A radiolabeled nonapeptide probe targeting PC-3 cells and bone metastases of prostate cancer in mice

Contrast Media and Molecular Imaging

Volumn 7, Issue 2, 2012, Pages 223-230

  Qinghua, Wu ^a,b   Jianli, Xu ^c   Lu, Liu ^a   Zexuan, Yang ^a   Guansheng, Tong ^c   Hailin, Gao ^a   Jianwei, Jiang ^b  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Isotope labeling; Molecular imaging; Polypeptide; Prostate cancer

Indexed keywords

FLUORESCENT DYE; INTERLEUKIN 11 RECEPTOR; NONAPEPTIDE; NONAPEPTIDE PENTETATE TECHNETIUM TC 99M; PENTETATE TECHNETIUM TC 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BONE METASTASIS; CELL LINE; CELL MEMBRANE; DRUG UPTAKE; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; ISOTOPE LABELING; MALE; MOLECULAR IMAGING; MOLECULAR PROBE; MOUSE; NONHUMAN; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; RADIORECEPTOR ASSAY; STAINING;

AMINO ACID SEQUENCE; ANIMALS; BINDING, COMPETITIVE; BONE NEOPLASMS; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORESCENCE; HUMANS; MALE; MICE; MOLECULAR PROBES; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PROSTATIC NEOPLASMS; RECEPTORS, INTERLEUKIN-11; TECHNETIUM TC 99M MEDRONATE; TECHNETIUM TC 99M PENTETATE; TISSUE DISTRIBUTION;

EID: 84858722973     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.486     Document Type: Article

References (22)

1. Cook RJ, Major P. Multistate analysis of skeletal events in patients with bone metastases. Clin Cancer Res 2006; 12(10): 6264-6269; doi: 10.1158/1078-0432.CCR-06-0654.
2. Morgentaler A. Testosterone and prostate cancer: a historical perspective on a modern myth. Eur Urol 2006; 50(5): 935-939.
3. Kido S, Kuriwaka-Kido R, Imamura T, Ito Y, Inoue D, Matsumoto T. Mechanical stress induces Interleukin-11 expression to stimulate osteoblast differentiation. Bone 2009; 45(6): 1125-1132; doi: 10.1016/j.bone.2009.07.087.
4. Morgan H, Tumber A, Hill PA. Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor. Int J Cancer 2004; 109(5): 653-660; doi: 10.1002/ijc.20056.
5. Kang Y, He W, Tulley S, Gupta GP, Serganova I, Chen CR, Todorova KM, Blasberg R, Gerald WL, Massagué J. Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc Natl Acad Sci USA 2005; 102(39): 13909-13914; doi: 10.1073/pnas.0506517102.
6. Javelaud D, Mohammad KS, McKenna CR, Fournier P, Luciani F, Niewolna M, André J, Delmas V, Larue L, Guise TA, Mauviel A. Stable overexpression of Smad in human melanoma cells impairs bone metastasis. Cancer Res 2007; 67(5): 2317-2324; doi: 10.1158/0008-5472.CAN-06-3950.
7. Zurita AJ, Troncoso P, Cardó-Vila M, Logothetis CJ, Pasqualini R, Arap W. Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancer. Cancer Res 2004; 64(2): 435-439; doi: 10.1158/0008-5472.CAN-03-2675.
8. Hanavadi S, Martin TA, Watkins G, Mansel RE, Jiang WG. Expression of interleukin 11 and its receptor and their prognostic value in human breast cancer. Ann Surg Oncol 2006; 13(6): 802-808.
9. Campbell CL, Jiang Z, Savarese DM, Savarese TM. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma. Am J Pathol 2001; 158(1): 25-32.
10. Bravo J, Heath JK. Receptor recognition by gp130 cytokines. EMBO J 2000; 19(11): 2399-2411.
11. Tacken I, Dahmen H, Boisteau O, Minvielle S, Jacques Y, Grotzinger J, Kuster A, Horsten U, Blanc C, Montero-Julian FA, Heinrich PC, Muller-Newen G. Definition of receptor binding sites on human interleukin-11 by molecular modeling-guided mutagenesis. Eur J Biochem 1999; 265(2): 645-655.
12. Lewis VO, Ozawa MG, Deavers MT, Wang GY, Shintani T, Arap W, Pasqualini R. The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples. Cancer Res 2009; 69(5): 1995-1999; doi: 10.1158/0008-5472.CAN-08-4845.
13. Cardó-Vila M, Zurita AG, Giordano RJ, Cardo-Vila M, Zurita AJ, Giordano RJ, Sun J, Rangel R, Guzman-Rojas L, Anobom CD, Valente AP, Almeida FC, Lahdenranta J, Kolonin MG, Arap W, Pasqualini R. A ligand peptide motif selected from a cancer patient is a receptor-interacting site within human interleukin-11. PLoS One 2008; 3(10): e3452-e3458.
14. Ernst M, Najdovska M, Grail D, Lundgren-May T, Buchert M, Tye H, Matthews VB, Armes J, Bhathal PS, Hughes NR, Marcusson EG, Karras JG, Na S, Sedgwick JD, Hertzog PJ, Jenkins BJ. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 2008; 118(5): 1727-1738.
15. Nandurkar HH, Hilton DJ, Nathan P, Willson T, Nicola N, Begley CG. The human IL-11 receptor requires gp130 for signalling:demonstration by molecular cloning of the receptor. Oncogene 1996; 12(3): 585-593.
16. Arap W, Kolonin MG, Trepel M, Lahdenranta J, Cardo-Vila M, Giordano RJ, Mintz PJ, Ardelt PU, Yao VJ, Vidal CI, Chen L, Flamm A, Valtanen H, Weavind LM, Hicks ME, Pollock RE, Botz GH, Bucana CD, Koivunen E, Cahill D, Troncoso P, Baggerly KA, Pentz RD, Do KA, Logothetis CJ, Pasqualini R. Steps toward mapping the human vasculature by phage display. Nat Med 2002; 8(2): 121-126.
17. Wang W, Shi K, Kwon S, Yallampalli S, Cameron AG, Adams KE, Mawad ME, Sevick-Muraca EM. A new optical and nuclear dual-labeled imaging agent targeting interleukin-11 receptor alpha-chain. Bioconjug Chem 2007; 18(2): 397-402.
18. Shah K, Weissleder R. Molecular optical imaging: applications leading to the development of present day therapeutics. NeuroRx 2005; 2(2): 215-225.
19. Li C, Wang W, Wu Q, Ke S, Houston J, Muraca SE, Dong L, Chow D, Charnsangavej C, Gelovani JG. Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe. Nucl Med Biol 2006; 33(3): 349-358.
20. Wu TT, Sikes RA, Cui Q, Thalmann GN, Kao C, Murphy CF, Yang H, Zhau HE, Balian G, Chung LW. Establishing human prostate cancer cell xenografts in bone induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 1998; 77(6): 887-894.
21. Fisher JL, Schmitt JF, Howard ML, Mackie PS, Choong PF, Risbridger GP. An in vivo model of prostate carcinoma growth and invasion in bone. Cell Tissue Res 2002; 307(3): 337-345.
22. Andresen C, Bagi CM, Adams SW. Intra-tibial injection of human prostate cancer cell line CWR22 elicits osteoblastic response in immunodeficient rats. J Musculoskelet Neuronal Interact 2003; 3(2): 48-155.